This article aims to deeply implement the centralized drug volume-based procurement policy issued by the General Office of the State Council, according to "Opinions on Promoting the Normalization of Centralized Bulk Procurement of Drugs" (by State Council Office [2021] No.2), promote rational use of drugs and guarantee the medication safety, as well as ensure the management normalization of centralized procurement of drugs based on the official standard in medical institutions at all levels. In June 2021, the Chinese Pharmacists Association, together with the First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Xuanwu Hospital of Capital Medical University, Shanghai Changzheng Hospital, Guangdong Provincial People's Hospital, Sichuan Provincial People's Hospital, Xijing Hospital of Air Force Military Medical University, the First Bethune Hospital of Jilin University, and Henan Provincial People's Hospital, gathered up 302 scholars as co-leaders from 128 first-class hospitals in 31 provincial areas. The first draft of Consensus of Chinese experts on the Implementation of Scientific Management of National Centralized Drug volume-based Procurement in Medical Institutions, co-authored by those experts, was released to gather public opinions on the official website of the Chinese Pharmacists Association in July 2022. Meanwhile, in order to draw on the scientific management measures taken by medical institutions of different levels to implement the centralized bulk procurement policy, we have collected suggestions from 276 experts and scholars from 201 medical institutions (including 46 community medical institutions) nationwide. It is proved that the reached consensus can be a good reference for wide-range areas. The Consensus is based on the whole process of centralized bulk procurement of drugs carried out in medical institutions, and focuses on the practice, providing individualized and targeted management measures and guidance for rational use of drugs in clinical settings. Refined management of the procurement process have been achieved by doing so, which contributes to the normalization of the centralized bulk procurement.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |